A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests.
A new approach to schizophrenia involves managing early psychosis symptoms and keeping young people in school or jobs. The treatment is effective, but private insurance plans don't usually cover it.
Flovent — a common asthma inhaler — will be discontinued in 2024. There will be a generic version available, but the change could make it hard for some patients to get their medication.
To treat amblyopia, or lazy eye, doctors typically prescribe a patch to cover the stronger eye and make the brain learn to work with the weaker one. Virtual reality offers a new approach.
In early December, the Food and Drug Administration approved a gene-editing treatment for sickle cell disease, the first for any illness. One patient helped pave the way.
Doxy-PEP can be taken a few hours after sex and is effective at preventing sexually transmitted infections. New research finds it's less effective for women but that may not be the final word.
An experimental technology that might someday allow infertile couples, as well as gay and trans couples, to have genetically related children stirs hope. So far, the technique has worked in mice.
The Food and Drug Administration approved two genetic treatments for sickle cell disease, including one that uses gene-editing. The approvals offer hope for patients and signal a new medical era.
A small study found that electrically stimulating an area deep in the brain allowed people with severe traumatic brain injuries to complete a cognitive test more quickly.
A Montana treatment center is one of two places in the U.S. offering long-term residential behavioral treatment for kids as young as 4. Now, administrators say it might have to close.
A new survey finds more people are surviving lung cancer and racial disparities are shrinking. But unless it's caught early, lung cancer still has a low survival rate.
The flu almost killed a 34-year-old man who was addicted to vaping. But an innovative doctor – and some DD-sized breast implants – made him eligible for a transplant.
Advisers to the Food and Drug Administration meeting Tuesday paved the way for the first treatment of human disease using the gene-editing technique CRISPR. The agency has a December deadline.
